PTC THERAPEUTICS, INC. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q2 2012 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Ptc Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2012 to Q2 2024.
  • Ptc Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 76.7M shares, a 2.67% increase year-over-year.
  • Ptc Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 74.8M shares, a 4.34% increase from 2022.
  • Ptc Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 71.7M shares, a 1.79% increase from 2021.
  • Ptc Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 70.5M shares, a 6.72% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 76.7M +1.99M +2.67% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 76.5M +2.77M +3.75% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-25
Q4 2023 74.8M +3.11M +4.34% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 75.4M +3.72M +5.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-10-26
Q2 2023 74.7M +3.36M +4.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 73.7M +2.51M +3.53% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-25
Q4 2022 71.7M +1.26M +1.79% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 71.7M +1.07M +1.51% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-26
Q2 2022 71.4M +958K +1.36% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 71.2M +1.03M +1.46% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-27
Q4 2021 70.5M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 70.6M Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-27
Q2 2021 70.4M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 70.2M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q3 2013 23.8M +23.8M Jul 1, 2013 Sep 30, 2013 10-Q 2013-11-14
Q2 2013 2.65M +2.64M Apr 1, 2013 Jun 30, 2013 10-Q 2013-08-13
Q3 2012 4.55K* Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 10.8K* Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.